Analysis identifies CYP1B1 as a key target in intervertebral disc degeneration, suggesting therapeutic drugs for clinical treatment.
No takes yet. Share an insight, caveat, or question.
Yu-kui et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: